← Eichor
Condition: Metabolic Dysfunction Associated Fatty Liver Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Metabolic Dysfunction Associated Fatty Liver Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Li
Phase N/A · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07652892Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Phase 2 · 5 location(s) · Regeneron Pharmaceuticals · NCT07527910Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
Phase 4 · 1 location(s) · Seoul National University Bundang Hospital · NCT06989723Implementing Food Referrals for Equity and Sustained Health
Phase 2 · 2 location(s) · University of California, San Diego · NCT06661538Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06813508A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Phase 1 · 3 location(s) · GlaxoSmithKline · NCT07358546Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NA · 2 location(s) · Pichamol Jirapinyo, MD, MPH · NCT06138821Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD
Phase N/A · 1 location(s) · Fundacion de Investigacion Science and Education · NCT06495333The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults
NA · 1 location(s) · Fujian Provincial Hospital · NCT06717828Effect of Insulin Lowering on Lipogenesis
Phase 1 · 1 location(s) · Columbia University · NCT07403604Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Non
NA · 3 location(s) · State Key Laboratory of Subhealth Intervention Technology · NCT07083336Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
NA · 3 location(s) · E-Scopics · NCT06661655EVOO and Metabolic Liver Health in MASLD
NA · 1 location(s) · Azienda Ospedaliera Specializzata in Gastroenterologia Saver · NCT07412444Spleen Stiffness Measurement for the Detection of Advanced Fibrosis
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07440511Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
Phase N/A · 1 location(s) · Richmond Research Institute · NCT04873258SMART Diets for MASLD
Phase 2 · 1 location(s) · Michigan State University · NCT07459504Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD
NA · 1 location(s) · Taipei Medical University · NCT07692438Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD
NA · 1 location(s) · Hospices Civils de Lyon · NCT07313007The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patient
NA · 3 location(s) · University of Nottingham · NCT07093346Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
NA · 1 location(s) · Weill Medical College of Cornell University · NCT05332613Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis
NA · 1 location(s) · Universitas Diponegoro · NCT06585982Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity
NA · 9 location(s) · Nantes University Hospital · NCT07378072A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From
Phase N/A · 1 location(s) · The Affiliated Hospital of Hangzhou Normal University · NCT07241195A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or
Phase 3 · 53 location(s) · GlaxoSmithKline · NCT07221188LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · 444 location(s) · Boehringer Ingelheim · NCT06632457Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Diseas
Phase 2 · 1 location(s) · AB Biotics, SA · NCT07193927A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction
Phase 3 · 356 location(s) · Akero Therapeutics, Inc · NCT06215716Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme
Phase N/A · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT07658755Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
NA · 1 location(s) · Université de Sherbrooke · NCT06843148
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.